Aligning pharmaceutical innovation with medical need

被引：35

作者：

Nathan, Carl ^{[1
]}

机构：

[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

来源：

NATURE MEDICINE | 2007年 / 13卷 / 03期

关键词：

D O I：

10.1038/nm0307-304

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：304 / 308

页数：5

相关论文

共 32 条

[1] Abramowicz M, 2003, VANDERBILT LAW REV, V56, P115
[2] The patents-based pharmaceutical development process: Rationale, problems, and potential reforms
Barton, JH
Emanuel, EJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (16): : 2075 - 2082
[3] Universities urged to do more for poor nations
Check, Erika
[J]. NATURE, 2006, 444 (7118) : 412 - 413
[4] Global framework on essential health R&D
Chirac, P
Torreele, E
[J]. LANCET, 2006, 367 (9522) : 1560 - 1561
[5] New antibiotics from bacterial natural products
Clardy, Jon
Fischbach, Michael A.
Walsh, Christopher T.
[J]. NATURE BIOTECHNOLOGY, 2006, 24 (12) : 1541 - 1550
[6] Drug discovery in jeopardy
Cuatrecasas, Pedro
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (11) : 2837 - 2842
[7] Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
Patricia M. Danzon
Adrian Towse
[J]. International Journal of Health Care Finance and Economics, 2003, 3 (3): : 183 - 205
[8] DUGGER C, 2006, NY TIMES 1201, pA9
[9] Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, William
Jensen, Paul R.
[J]. NATURE CHEMICAL BIOLOGY, 2006, 2 (12) : 666 - 673
[10] Paying for performance - Risks and recommendations
Fisher, Elliott S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (18) : 1845 - 1847

← 1 2 3 4 →